Susquehanna International Group’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$888K Buy
231,766
+166,458
+255% +$638K ﹤0.01% 3442
2025
Q1
$376K Sell
65,308
-26,438
-29% -$152K ﹤0.01% 4730
2024
Q4
$458K Buy
91,746
+64,314
+234% +$321K ﹤0.01% 4204
2024
Q3
$148K Buy
27,432
+10,669
+64% +$57.5K ﹤0.01% 4961
2024
Q2
$55.5K Sell
16,763
-23,154
-58% -$76.6K ﹤0.01% 5257
2024
Q1
$131K Sell
39,917
-162,279
-80% -$531K ﹤0.01% 4905
2023
Q4
$710K Sell
202,196
-139,214
-41% -$489K ﹤0.01% 3353
2023
Q3
$2.28M Buy
341,410
+99,743
+41% +$666K ﹤0.01% 1720
2023
Q2
$2.03M Sell
241,667
-856,501
-78% -$7.19M ﹤0.01% 1891
2023
Q1
$10.9M Buy
1,098,168
+852,019
+346% +$8.46M ﹤0.01% 697
2022
Q4
$1.71M Buy
246,149
+113,455
+86% +$790K ﹤0.01% 1733
2022
Q3
$709K Buy
132,694
+60,452
+84% +$323K ﹤0.01% 3025
2022
Q2
$288K Buy
72,242
+30,528
+73% +$122K ﹤0.01% 4048
2022
Q1
$185K Sell
41,714
-89,774
-68% -$398K ﹤0.01% 4871
2021
Q4
$526K Sell
131,488
-39,626
-23% -$159K ﹤0.01% 3716
2021
Q3
$1.5M Buy
171,114
+54,655
+47% +$480K ﹤0.01% 2256
2021
Q2
$1.32M Sell
116,459
-154,268
-57% -$1.75M ﹤0.01% 2615
2021
Q1
$3.22M Buy
270,727
+194,854
+257% +$2.31M ﹤0.01% 1610
2020
Q4
$520K Buy
75,873
+62,247
+457% +$427K ﹤0.01% 3361
2020
Q3
$101K Sell
13,626
-6,646
-33% -$49.3K ﹤0.01% 4090
2020
Q2
$85K Sell
20,272
-3,221
-14% -$13.5K ﹤0.01% 3940
2020
Q1
$58K Buy
23,493
+6,254
+36% +$15.4K ﹤0.01% 4168
2019
Q4
$100K Sell
17,239
-11,790
-41% -$68.4K ﹤0.01% 3670
2019
Q3
$153K Sell
29,029
-18,130
-38% -$95.6K ﹤0.01% 3955
2019
Q2
$283K Buy
47,159
+30,893
+190% +$185K ﹤0.01% 3531
2019
Q1
$147K Sell
16,266
-9,170
-36% -$82.9K ﹤0.01% 2597
2018
Q4
$211K Buy
25,436
+10,397
+69% +$86.2K ﹤0.01% 2879
2018
Q3
$208K Buy
+15,039
New +$208K ﹤0.01% 2726
2018
Q2
Sell
-44,084
Closed -$331K 3606
2018
Q1
$331K Buy
+44,084
New +$331K ﹤0.01% 2467